Matches in Wikidata for { <http://www.wikidata.org/entity/Q66040774> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q66040774 description "clinical trial" @default.
- Q66040774 description "ensayu clínicu" @default.
- Q66040774 description "klinisch onderzoek" @default.
- Q66040774 description "клінічне випробування" @default.
- Q66040774 description "կլինիկական փորձարկում" @default.
- Q66040774 name "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 name "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 type Item @default.
- Q66040774 label "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 label "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 prefLabel "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 prefLabel "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV" @default.
- Q66040774 P1132 Q66040774-7249334E-EF88-458B-B3AC-5A9A25451EA8 @default.
- Q66040774 P1476 Q66040774-67BDC4EC-23AC-46E2-B784-B4AE65A38CEA @default.
- Q66040774 P17 Q66040774-6AB23854-9C94-4837-9CC5-73D62FBA9574 @default.
- Q66040774 P2899 Q66040774-A76977AE-9809-4446-B047-5805068E3B11 @default.
- Q66040774 P3098 Q66040774-55A808CB-B32A-4285-8864-7695E797A745 @default.
- Q66040774 P31 Q66040774-A7257E81-7EF9-4A1D-B243-1B3F42CD537D @default.
- Q66040774 P4844 Q66040774-E7504E30-9796-451A-8CED-EAB8D9D1D8BD @default.
- Q66040774 P580 Q66040774-0C58CE2B-F678-46ED-BA79-81E5D8B02B13 @default.
- Q66040774 P6099 Q66040774-5239E2ED-AC52-4D1E-81D8-F87A0C6C8E11 @default.
- Q66040774 P6153 Q66040774-0B818CD3-147A-46F9-8720-A67D8E536748 @default.
- Q66040774 P6153 Q66040774-68BE8E19-1CF4-44CE-AA1D-C2B71A97AF4F @default.
- Q66040774 P8363 Q66040774-61D89F01-6E3C-411F-9280-E3A6E8D62D5C @default.
- Q66040774 P1132 "+121" @default.
- Q66040774 P1476 "A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion" @default.
- Q66040774 P17 Q30 @default.
- Q66040774 P2899 "+16" @default.
- Q66040774 P3098 "NCT00000940" @default.
- Q66040774 P31 Q30612 @default.
- Q66040774 P4844 Q304330 @default.
- Q66040774 P580 "1999-05-01T00:00:00Z" @default.
- Q66040774 P6099 Q42824440 @default.
- Q66040774 P6153 Q13371 @default.
- Q66040774 P6153 Q1468161 @default.
- Q66040774 P8363 Q78089383 @default.